The fourth batch of collection in Zhejiang confirmed the inclusion of recombinant human growth hormone.

[Zhejiang fourth batch Collection confirmed to be included in Recombinant Human growth hormone] recently, a screenshot of a document entitled "notice on submitting the fourth batch of drugs in Zhejiang Province to centralized and quantitative Purchasing of varieties" has been circulated on the Internet. The date of registration is May 31, 2023. The attachment list includes Life growth hormone (Recombinant Human growth hormone). This may be the reason for the fluctuation of high-tech stock prices in Changchun today. In response, the reporter called the office of Zhejiang Pharmaceutical equipment Purchasing Center, which confirmed that the document had been released on the intranet, but so far it has not been released to the public, and the list does contain recombinant human growth hormone. (Securities Times)